Meet our wonderful Sandra, everyone!

Hi, I’m Sandra Fazackerley, Accounts & Administrative Coordinator at LDA Research. I first joined LDA in November 2022 as a Fieldwork Executive on a temporary three-week contract, helping the team with all things administrative — and here I am, four years later! Before joining LDA, I spent many years working in Executive Assistant roles, so […]
The Longest Journey: How Rare Disease Networks are Transforming Patient Journeys

Rare Disease Networks Perspectives Series – Blog 4/5 The Longest Journey: How Rare Disease Networks are Transforming Patient Journeys There is a particular kind of loneliness that comes with a rare disease diagnosis. It is not only the uncertainty of a condition that few clinicians have encountered, or the exhaustion of a care journey that […]
The Ethics of Asking: Researching Sensitive Health Topics Well

Patient sensitivity is vital to medical market research. We believe an ethical approach to researching sensitive health topics is essential to good quality research. Ensuring a patient receives proper treatment is the baseline of our research and we employ case by case methods to ensure this. Ethical approaches toward patients guarantees better data quality, harm […]
Rare Disease Networks Perspectives Series – Blog 3 out of 5: Policy, Protection, and Progress: The Regulatory Perspective on Rare Disease Networks

Regulation, by its nature, is cautious. Agencies tasked with protecting public health are not designed to move fast; they are designed to be rigorous. Yet rare diseases have, from the very beginning, placed regulators in an uncomfortable position. The same caution that protects patients from unsafe or ineffective treatments also, if applied without adaptation, denies […]
Meet our team member Susana!

Hi, I’m Susana Londono, a Research Manager at LDA Research, specialising in research across Latin America and Spain. I joined LDA in June 2024, bringing with me a background in market research, having previously worked as a research analyst. My role involves managing projects from end to end, coordinating with clients and stakeholders, and leading […]
From Orphan to Opportunity: The Evolution of Pharmaceutical Engagement in Rare Disease Networks

For most of the twentieth century, the pharmaceutical industry’s relationship with rare diseases could be summarised in a single phrase: studied indifference. The economics were simply prohibitive. Small patient populations meant limited revenue potential; limited revenue meant that even promising science rarely attracted the capital needed to progress from laboratory to clinic. The FDA estimated […]
Fraud-Proofing Medical Market Research: Why Human-Led Verification Matters More Than Ever

As medical market research has moved increasingly online, and as social media has widened access to recruitment opportunities, fraud prevention has become more important than ever. The ways in which fraudulent respondents attempt to enter studies have also become more sophisticated. Tackling fraudulent responses is no longer simply a case of spotting duplicate email addresses […]
From Isolation to Infrastructure – The Origins of Rare Disease Networks (blog 1/5)

Across the world, an estimated 300 to 400 million people live with a rare disease. Yet for most of the twentieth century, these individuals lived in near-total isolation – medically, scientifically, and politically. No treatments, no dedicated research programmes, and no networks to connect the at times handful of patients and clinicians who shared the […]
Living and Learning with Paroxysmal Nocturnal Hemoglobinuria (PNH): A Personal Journey Through Rare Disease

The Day Something Felt “Not Quite Right” One ordinary day, I suddenly had a nosebleed. That alone isn’t unusual—I’ve had them before. But this time, the blood flowed far too smoothly, almost like a water tap being turned on. That’s strange, I remember thinking. It didn’t feel like a typical nosebleed at all. By evening, […]
Successes and Challenges in the Diagnosis and Treatment of Rare Diseases

By Leigh Hart, Senior Moderator @ LDA Research Rare diseases affect an estimated 300–400 million people worldwide, yet progress in diagnosis and treatment has historically been slow. Small patient populations, limited commercial incentives, and gaps in clinical knowledge have long created barriers. In recent years, however, genuine hope has emerged. Because of rare disease networks, […]
A Journey of Resilience: Marcus’ Fight Against Rare GRIN2A Disorder (Part 2)

At LDA Research, we know that behind every data point is a real person, a real family, and a real story. We’re sharing one of those stories from Mariah from Minnesota, USA. It’s a story about her, her son and navigating a rare disease diagnosis, the challenges of accessing specialized care, and what she’s learned […]